vimarsana.com

Latest Breaking News On - Abrdn life sciences investors stock - Page 1 : vimarsana.com

Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Purchases $133,041.84 in Stock

Abrdn Life Sciences Investors (NYSE:HQL – Get Free Report) major shareholder Saba Capital Management, L.P. bought 9,704 shares of the firm’s stock in a transaction dated Monday, June 10th. The stock was bought at an average cost of $13.71 per share, with a total value of $133,041.84. Following the transaction, the insider now directly owns […]

Securities-exchange-commission
Karpus-management-inc
Abrdn-life-sciences-investors-increases-dividend
Institutional-trading-of-abrdn-life-sciences-investors
Abrdn-life-sciences-investors-stock
Advisors-asset-management-inc
Cetera-advisors
B-riley-wealth-advisors-inc
Quarter-for-abrdn-life-sciences-investors
Abrdn-life-sciences-investors
Get-free-report

Quantedge Capital Pte Ltd Acquires 35,700 Shares of Abrdn Life Sciences Investors (NYSE:HQL)

Quantedge Capital Pte Ltd Acquires 35,700 Shares of Abrdn Life Sciences Investors (NYSE:HQL)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Quarter-for-abrdn-life-sciences-investors
Abrdn-life-sciences-investors
Abrdn-life-sciences-investors-stock
Quad-cities-investment-group
Abrdn-life-sciences-investors-increases-dividend
B-riley-wealth-advisors-inc
Holdings-channel
Wealth-management
Quantedge-capital-pte-ltd
Money-concepts-capital-corp
Blue-bell-private-wealth-management
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.